Patients workflows and acquisition protocols in PET/CT and PET/MR with different radiotracers for cardiovascular nuclear medicine imaging. Learning Objectives: To learn how to manage radioactive generators 82Sr/82Rb and to acquire […]
A large oncological framework will be the topic of the first session: three lectures by a high quoted Paediatric Oncologist: epidemiology, aetiological factors, and general classification of Paediatric Hodgkin and […]
General overview of the EANM/SNMMI guidelines on FDG PET/CT in inflammation and infection. Learning Objectives: The aim of this course is to summarize the major indications for FDG PET/CT in […]
Radionuclide Theranostics is evolving and expanding in the field of nuclear medicine in various clinical settings. Its principle is based on therapeutic interventions after imaging to confirm the presence of […]
Breast cancer is the most common cancer in women worldwide and it is still one of the leading causes of morbi-mortality, therefore being a major concern. 2-FDG PET/CT is commonly […]
The webinar will cover the most relevant methodological aspects of nuclear medicine techniques in paediatric nephrourology, with particular attention to the choice of the radiotracer, the correct patient preparation, and […]
This course provides a comprehensive overview of nuclear medicine imaging of coronary artery disease. General aspects, details of radiotracers utilised, examination protocols and case examples of myocardial perfusion imaging (MPI) […]
The rapid development in machine learning has generated new artificial intelligence (AI) based methods for improving dosimetry within nuclear medicine. This webinar will present the current status of AI within […]
The course has a hybrid format with on-site lectures and hands-on practical and technic sessions, It will cover the basic and some advanced and future aspects of Radioguided surgery with […]
While PET imaging with radionuclides such as F18 and Ga68 have proven to provide high quality diagnostic imaging, imaging with other radionuclides can be more challenging. Zr-89 is one such […]
The advent of FDA approved anti-AB drugs such as Aducanumab and Lecanemab is changing not only the therapeutic prospectives for patients but also the diagnostic flow-charts. However, due to differences in […]
With the arrival of new therapeutic tracers, nuclear medicine has a new arsenal to treat metastatic bone pain. This presentation aims to give the keys to define the place of […]
European School of Multimodality Imaging & Therapy (ESMIT)
Schmalzhofgasse 26
1060 Vienna
Austria
phone +43 1 890 44 27
e-mail esmit@eanm.org
